Buprenorphine Hcl

   
Google
 
Web NewDrugInformation.com

Buprenorphine Hcl


Drug - Buprenorphine Hcl
The trade name of the product as shown on the labeling.

Dosage - INJECTABLE; INJECTION
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Buprenorphine Hydrochloride
Multiple ingredients are in alphabetical order.

Strength - EQ 0.3MG BASE/ML
The potency of the active ingredient(s), Buprenorphine Hydrochloride. May repeat for multiple part products.

Applicant - BEDFORD
The firm name holding legal responsibility for Buprenorphine Hcl. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 076931
The FDA assigned number to Buprenorphine Hcl. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Buprenorphine Hcl. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AP
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Mar 2, 2005
The date Buprenorphine Hcl was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Buprenorphine Hcl. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Buprenorphine Hcl is in. Format is RX, OTC, DISCN.

Applicant Full Name - Bedford Laboratories Div Ben Venue Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Buprenorphine Hcl.

Buprenorphine Hcl